HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment results of stage I oral tongue cancer with definitive radiotherapy.

Abstract
The medical records of 133 patients with Stage I tongue cancer treated by definitive radiotherapy between 1966 and 2001 were reviewed. Overall survival rate (OS), progression free survival rate (PFS), and survival rate after recurrence were calculated according to the Kaplan-Meier method. We investigated prognostic factors for local control and risk factors of late neck LN metastasis. The 5-year OS was 81.8% and the 5-year PFS was 67.2%. The 5-year OS after local recurrence was 100% by salvage operation, and that after neck LN metastasis was 40.7% despite radical neck dissection. Tumor thickness over 5 mm and treatment without interstitial irradiation were prognostic factors for local control. Tumor diameter over 15 mm and tumor thickness over 5 mm were risk factors of late neck LN metastasis. We should consider prophylactic treatment for neck LN for high risk patients with Stage I tongue cancer in order to improve treatment results further.
AuthorsYukako Ichimiya, Nobukazu Fuwa, Minoru Kamata, Takeshi Kodaira, Kazuhisa Furutani, Hiroyuki Tachibana, Natsuo Tomita, Satoshi Hidano
JournalOral oncology (Oral Oncol) Vol. 41 Issue 5 Pg. 520-5 (May 2005) ISSN: 1368-8375 [Print] England
PMID15878758 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brachytherapy (adverse effects, methods, mortality)
  • Carcinoma, Squamous Cell (mortality, pathology, radiotherapy)
  • Disease-Free Survival
  • Female
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (mortality)
  • Neoplasms, Second Primary (mortality)
  • Retrospective Studies
  • Risk Factors
  • Tongue Neoplasms (mortality, pathology, radiotherapy)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: